Daqing Huake Company Limited Daqing Huake Company Limited engages primarily in the research, development, manufacture, and sale of petrochemical products and fine chemicals in China. The company produces C9 series petroleum resins, C5 series petroleum resins, polypropylene and its modified products including polypropylene powder, hydrogenated pentene, light aromatic hydrocarbons, heavy aromatic hydrocarbons, paraffin, cracking heavy fraction products, industrial acetonitrile, and ethylene bottom oil; it also offers pharmaceuticals and health care products such as cold capsules and royal jelly capsules, alongside plastic products like polypropylene woven bag coating materials and polyethylene insulation for communication cables. Founded in December 1998 and headquartered at No. 8 Xinghua North Street, Longfeng District, Daqing City, Heilongjiang Province, China, Daqing Huake Company Limited primarily serves domestic markets with exports to approximately 20 countries in Europe, Southeast Asia, and North America, employing around 450 people and operating in the basic materials sector focused on chemicals. In recent developments, the company released its 2025 third-quarter report reflecting operating revenue performance amid cost pressures and proposed a final dividend for fiscal 2024 payable in June 2025, while continuing to pursue state-owned share transfers involving its Linyuan refinery holdings as part of ongoing ownership restructuring.